Viewing Study NCT00787566


Ignite Creation Date: 2025-12-24 @ 4:42 PM
Ignite Modification Date: 2025-12-29 @ 8:54 AM
Study NCT ID: NCT00787566
Status: COMPLETED
Last Update Posted: 2011-07-12
First Post: 2008-11-05
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase 2 Study of Efficacy, Tolerability, and Safety of Intranasal Granisetron for Chemo-Induced Nausea and Vomiting
Sponsor: Shin Nippon Biomedical Laboratories, Ltd.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: TRG-002
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Vanaja Ragavan, MD
Old Organization: Aviana Consulting, LLC

Collaborators